Coherus Oncology, Inc. CHRS
Performance
| Periode | CHRS | CTMX | NUVB | ASMB | LYRA | ATRA | FGEN | MGNX | BPMC |
|---|---|---|---|---|---|---|---|---|---|
| 6M | 99.78 % | 530.99 % | 87.94 % | 191.96 % | 50.10 % | 159.04 % | 52.24 % | 31.01 % | 39.99 % |
| YTD | 19.29 % | 216.98 % | 44.40 % | 54.58 % | -28.98 % | 1.17 % | -20.26 % | -48.79 % | 48.46 % |
| 1Y | 77.83 % | 208.26 % | 62.61 % | 55.85 % | -31.09 % | 75.77 % | 22.96 % | -60.51 % | 35.28 % |
| 3Y | -80.33 % | 133.33 % | 71.56 % | 32.29 % | -96.86 % | -85.46 % | -97.02 % | -49.40 % | 111.64 % |
| 5Y | -90.96 % | -50.95 % | -65.34 % | -85.77 % | -98.80 % | -96.08 % | -99.14 % | -93.35 % | 71.29 % |
| 10Y | -92.69 % | -73.29 % | -62.60 % | -78.86 % | -99.17 % | -98.27 % | -98.03 % | -92.91 % | 335.16 % |
| From the beginning | -86.76 % | -73.95 % | -62.60 % | -92.99 % | -99.17 % | -94.62 % | -98.08 % | -93.24 % | 586.06 % |